| |
| Magyar Immunológiai Társaság |
|
| 13th EFIS-EJI Tatra Immunology Conference (June 9 - 13, 2018) |
 Rendezvény kezdete: 2018.06.09. | Rendezvény vége: 2018.06.13. |
| Szakterület(ek): Allergológia, klinikai immunológia |
| Helyszín: Slovakia, Štrbské Pleso, |
| A rendezvény Web oldala: https://tatra.img.cas.cz/ |
Venue: Hotel Patria, which is located on Štrbské Pleso (the mountainside of the High Tatras).
Date: June 9 - 13, 2018
The 13th EFIS-EJI Tatra Immunology Conference will include lectures by invited speakers, poster presentations by other participants and informal discussions combined with extended midday recreational activities. The aim of the organizers is to have the conference in a style similar to the Gordon Conferences, i.e. with a lot of informal discussions and no written proceedings.
Participation is limited to approx. 120. If you are interested in participating, please register electronically via this site before February 28, 2018. You will be informed that your registration has been recieved and will be given the details about conference fee payment. Several poster presentations will be selected for brief oral presentations. The conference fee is 400 EUR and includes conference programme, 4 nights of accommodation (in single or double rooms), full subsistence, evening social programme, transport from the nearest airport (Kosice) and several trips during midday breaks.
A limited number of student fellowships (registration reduction by 200 or even 400 EUR) will be available upon request. More information about the stipends can be found in the section Fellowships.>>
More information on the website: https://tatra.img.cas.cz/ >>
|
|
|
 |
| |
| Magyar Immunológiai Társaság |
|
| 13th EFIS-EJI Tatra Immunology Conference (June 9 - 13, 2018) |
| Rendezvény kezdete: 2018.06.09. | Rendezvény vége: 2018.06.13. |
| Szakterület(ek): Allergológia, klinikai immunológia |
| Helyszín: Slovakia, Štrbské Pleso, |
| A rendezvény Web oldala: https://tatra.img.cas.cz/ |
Venue: Hotel Patria, which is located on Štrbské Pleso (the mountainside of the High Tatras).
Date: June 9 - 13, 2018
The 13th EFIS-EJI Tatra Immunology Conference will include lectures by invited speakers, poster presentations by other participants and informal discussions combined with extended midday recreational activities. The aim of the organizers is to have the conference in a style similar to the Gordon Conferences, i.e. with a lot of informal discussions and no written proceedings.
Participation is limited to approx. 120. If you are interested in participating, please register electronically via this site before February 28, 2018. You will be informed that your registration has been recieved and will be given the details about conference fee payment. Several poster presentations will be selected for brief oral presentations. The conference fee is 400 EUR and includes conference programme, 4 nights of accommodation (in single or double rooms), full subsistence, evening social programme, transport from the nearest airport (Kosice) and several trips during midday breaks.
A limited number of student fellowships (registration reduction by 200 or even 400 EUR) will be available upon request. More information about the stipends can be found in the section Fellowships.>>
More information on the website: https://tatra.img.cas.cz/ >>
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
| Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
| A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
| Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
| A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
| Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
| A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
| Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
| A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2011.05.19. | Rendezvény vége: 2011.05.22. |
| Helyszín: Spain / Spanyolország, Barcelona, Palau de Congressos de Catalunya |
| A rendezvény Web oldala: http://www.comtecmed.com/chep/2011/ |
Dear Friends and Colleagues,
The field of Viral Hepatitis is experiencing vast expansion in clinical trials and basic research, as well as in emerging cutting-edge technology. Exciting new drugs are soon becoming available.
The 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) will function as a comprehensive forum where international experts share and debate state-of-the-art management issues, such as appropriate use of new drugs, in order to outline the optimal treatment for patients.
This innovative Congress is unique in its explicit focus on resolving controversies related to clinical management and treatment of patients infected with viral hepatitis. Controversies raised by recent advances in Hepatitis care will be addressed throughout the comprehensive meeting.
Participants will have the advantage of discussing and debating these unresolved issues with leading world experts in all fields of Viral Hepatitis. Allowing ample time for speaker-audience discussion, the Congress aims at reaching up-to-date and agreed-upon answers to ongoing debates, even when data remains limited, through evidence-based medicine and expert opinion.
We invite you to take part in the 1st C-Hep Congress which is intended as the inaugural event of annual future editions.
We look forward to an exciting academic event in the beautiful city of Barcelona.
Sincerely,
Jürgen Rockstroh MD, Jonathan M. Schapiro MD
Co-Chairpersons
|
|
|
|
